ADVM—Just listened to the relevant portion of the CC, which starts at 1:09:45 (https://edge.media-server.com/mmc/p/ap5329mf ). I think this issue, which was raised by @sentivcapital on Twitter, is a false alarm. The doctor on the webcast is saying that steroid usage is generally not a concern in patients who are pseudophakic—he is not referring to patients in ADVM's trial.
News 
Market Data 
Discover 
